Crinetics

Spruce Biosciences

This biopharmaceutical company develops enzyme replacement therapies and small molecules for patients with rare endocrine and neurological disorders.

Amolyt Pharma

This clinical-stage biopharmaceutical company develops therapeutic peptides to treat patients with rare endocrine and related diseases, including hypoparathyroidism and acromegaly.

Radius Health

This biopharmaceutical company develops and commercialises endocrine therapies for patients with osteoporosis and other bone health conditions.

VectivBio

This company develops biopharmaceutical treatments for severe rare gastrointestinal conditions, including short bowel syndrome, for patients with orphan diseases.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Edgewise

This biopharmaceutical company develops oral small molecule therapies to treat patients with rare skeletal and cardiac muscle diseases.

ShouTi

This biopharmaceutical company develops oral small molecule therapeutics for patients with chronic metabolic, cardiovascular and pulmonary diseases.